date:Nov 06, 2012
ation of its products as nutritionists and herd managers look to continue to maximise results of production animals.
Sales in the Food, Pharma Nutrition segment were $10.9 million, effectively equal to the $11.0 million of the prior year comparable quarter. Balchem said that it realised continued strength in sales of its human choline products; however, it also saw a comparative quarter decline in the international food sector of encapsulated ingredients for the prepared food, preservation an